Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong · Delayed Price · Currency is HKD 474.40
-6.60 (-1.37%)
Sep 10, 2026, 4:08 PM HKT
HKG:6990 Stock Forecast
Stock Price Forecast
According to 19 analysts polled by S&P Global, HKG:6990 stock has a consensus rating of "Strong Buy" and an average price target of $618.43. The average 1-year stock price forecast is 30.36% higher than the current stock price, while the lowest is $520.00 (+9.61%) and the highest is $765.30 (+61.32%).
Price Target: $618.43 (+30.36%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HKG:6990 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 16 | 16 | 15 | 15 | 15 | 16 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 19 | 18 | 18 | 18 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst SDIC Securities No rating | SDIC Securities | Buy Maintains $571.39 | Buy | Maintains | $571.39 | +20.44% | Aug 28, 2026 |
Unknown Analyst Shenwan Hongyuan No rating | Shenwan Hongyuan | Buy Maintains $630.00 | Buy | Maintains | $630.00 | +32.80% | Aug 26, 2026 |
Unknown Analyst SPDB No rating | SPDB | Buy Maintains $611.60 → $624.00 | Buy | Maintains | $611.60 → $624.00 | +31.53% | Aug 21, 2026 |
Unknown Analyst BOCOM International Holdings Company No rating | BOCOM International Holdings Company | Buy Maintains $642.00 | Buy | Maintains | $642.00 | +35.33% | Aug 20, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $550.00 → $630.00 | Buy | Maintains | $550.00 → $630.00 | +32.80% | Aug 20, 2026 |
Financial Forecast
Revenue This Year
2.55B
from 2.06B
Increased by 23.98%
Revenue Next Year
4.48B
from 2.55B
Increased by 75.73%
EPS This Year
-0.09
from -1.04
EPS Next Year
3.55
from -0.09
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.